b'Gender Parity CollaborativeMember SpotlightsTamicka S. James Sheri MullenHEAD OF DIVERSITY AND INCLUSION, U.S. COMMERCIAL, MEDICAL, ANDSENIOR VICE PRESIDENT, U.S. SPECIALTYGOVERNMENT AFFAIRS (CMG) AT GENENTECH, A MEMBER OF THE ROCHE GROUP PHARMACEUTICALS, GSKWhat impact has the Gender Parity Collaborative had on your organization? What are someAs the first industry consortium working to accelerate systemic change, what specific wins as a result of your organizations engagement with the Collaborative?will lead the Collaborative to measurable positive outcomes?EXCERPTED At Genentech, we are committed to unifying the greatest minds within and beyond our diverseFROM 2020 The accountability factor of the Collaborative is very important. While sharing networks to solve the worlds most complex health challenges and improve the lives of allkey data and best practices is important, it takes holding hands across the patients. The industry leaders who comprise the Collaborative offer access to invaluableindustry to champion the business case for gender parity within each of our resources and expertise. individual organizations. The good news is like GSK, many of the organizations The HBA E.D.G.E. in Leadership Study inspired us to conduct our own research, which shapesinvolved in the Collaborative have been recognized externally for their inclusion our data driven strategic approach to ensure our workforce reflects our increasingly diverseand diversity efforts, and by coming together, we can act as an accelerator for world. Were leaning into data transparency as part of our commitment to D&I by sharinggender parity as well as hopefully extend our influence outward toward other data annually with employees related to gender and people of color representation and paycompanies.practices, as well as publishing our first Annual D&I Report.Its indisputable that we have a greater impact as a Collaborative than we can haveAs one of your organizations leaders, why are you personally committed to independently, and I am proud to be a part of a network of peers equally committed to D&Iadvancing gender parity in the workplace?work.As a leader, I believe I have a dual responsibility to help others be the best they can be, but also to help GSK achieve its vision of becoming one of the most As one of your organizations leaders, why are you personally committed to advancinginnovative, best performing, and trusted healthcare companies in the world.gender parity in the workplace? Gender parity aligns with both. Theres no better way for me to demonstrate My commitment to advancing gender parity in the workplace is rooted in my own experiencesmy commitment than to be a role model to others and to get involved in the organizations making a difference in gender parity like the HBA, so I invest the and the understanding that representation matters and visibility is key. Women and girlstime to do so.represent half of the worlds population and as the late Supreme Court Justice Ruth Bader Ginsburg so eloquently stated, Women belong in all places where decisions are being made. Women deserve to have an equal voice and be represented at all levels of leadership within an organization. I am honored to be an African American woman in a leadership position at Genentech. And with that comes the responsibility to ensure other women have the same opportunities byBy coming together, we can act as an accelerator 18 2021for gender parity as well as hopefully extend our19helping to ensure that our workforce reflects the populations we serve. Its in that reflection that we will continue our work to improve the lives of all patients. For this reason, I remain committed to challenging the status quo, stereotypes, gender bias, inequality, lack ofinfluence outward toward other companies.representation, and all the isms! SHERI MULLENIts indisputable that we have a greater impact as a Collaborative than we can have independently, and I am proud to be a partof a network of peers equally committed to D&I work.TAMICKA S. JAMESFor more info visit genderparity.HBAnet.org'